Mabcampath Intravenous infusion 30mg, manufactured by Sanofi, contains Alemtuzumab (genetical recombination), a monoclonal anti-CD52 antibody. It is used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. This 30mg 1mL bottle has a YJ code of 4291428A1029.
Mabcampath Intravenous infusion 30mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →